A cancer patient from Leeds has revealed how his complex robotic operation was cancelled - because of a shortage of hospital beds. Andrew Claridge says he was told in an email that the life saving procedure had to be postponed for weeks - because Leeds Teaching Hospitals Trust is experiencing unprecedented levels of demand. Victoria Whittam talks to Andrew and the vice president of the Royal College of Surgeons Ian Eardley.
A band of volunteers from across the country answered a Facebook appeal to renovate the home of a terminal cancer patient in Lincoln.Read the full story ›
A man from Leeds is raising awareness of the early signs of bile duct cancer after his wife of just five months died from the condition.Read the full story ›
A Lincolnshire father who lost his daughter to cancer has completed 13 half marathons in her memory.Read the full story ›
There is further evidence of a potential cancer cluster among former workers at the Staveley Chemicals plant near Chesterfiel.Read the full story ›
Cancer patients in Leeds are featuring in a new national campaign to urge people to take action early to beat the illness.Read the full story ›
A Lincolnshire toddler who is being treated for a brain tumour has had his courage recognised with a special award from Cancer Research UK.Read the full story ›
New figures reveal that an additional 185 people a year beat cancer through local measures to help early detection of the disease.Read the full story ›
A ground-breaking ceremony is being held this afternoon for the new £9 million Macmillan Cancer Centre at Chesterfield Royal Hospital.
Preparatory work is due to start shortly on the centre, which will see all the hospital's cancer services under one roof and helping to provide a purpose-built facility and comfortable environment within which patients can continue to receive top quality care.
A revolutionary new cancer drug designed by researchers in Leeds could change the way the disease is treated.
What makes it different is this drug doesn't require chemotherapy - it's an oral drug which has today been licenced for the NHS by NICE - the National Institute for Health and Clinical Excellence
The treatment, for leukaemia patients, could pave the way for a new methods of tackling the condition, as Victoria Whittam reports.